Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,864
Closed -$44.2K 6302
2026
Q1
$44.2K Buy
+10,864
New +$82.4K ﹤0.01% 5449
2025
Q3
Sell
-969
Closed -$8.43K 6376
2025
Q2
$8.43K Buy
+969
New +$12.7K ﹤0.01% 5724
2023
Q4
Sell
-790
Closed -$26.5K 6447
2023
Q3
$26.5K Buy
+790
New +$42.4K ﹤0.01% 5597
2023
Q2
Sell
-186
Closed -$20K 6574
2023
Q1
$20K Sell
186
-179
-49% -$24.1K ﹤0.01% 5865
2022
Q4
$43K Buy
365
+332
+1,006% +$52.9K ﹤0.01% 5827
2022
Q3
$6K Sell
33
-24
-42% -$5.36K ﹤0.01% 6770
2022
Q2
$12K Buy
+57
New +$14.2K ﹤0.01% 6620
2016
Q1
Hold
0
-$24K 3583
2015
Q4
Hold
0
3338
2015
Q3
Hold
0
3093
2015
Q2
Hold
0
2768
2014
Q1
Hold
0
-$140K 3809
2013
Q4
Hold
0
3306

Other funds holding CNSY

Israel Englander's CNSY Position: Q2 2026 in Review

Israel Englander sold out of Cerenome (CNSY) in Q2 2026, closing a stake of 10,864 shares — an estimated $44.2K sold.

Israel Englander first reported a position in CNSY in Q2 2022 and held it in 7 quarters. The position peaked at $44.2K in Q1 2026. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Israel Englander reported no remaining Cerenome position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 10,864 Cerenome shares in Q2 2026, an estimated $44.2K.
  • Israel Englander first reported a position in Cerenome in Q2 2022 and held it in 7 quarters.
  • Israel Englander's Cerenome position peaked at $44.2K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.